Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ST3GAL1 |
| Upstream (Parents) |
|---|
| (<<) CBS → ST3GAL1 |
| (<<) CXCL2 → ST3GAL1 |
| (<<) EPHB2 → ST3GAL1 |
| (<<) FAS → ST3GAL1 |
| (<<) HYAL1 → ST3GAL1 |
| (<<) MT1P2 → ST3GAL1 |
| (<<) NR3C1 → ST3GAL1 |
| (<<) ORM1 → ST3GAL1 |
| (<<) RBKS → ST3GAL1 |
| (<<) SAA4 → ST3GAL1 |
| (<<) SET → ST3GAL1 |
| (<<) ST3GAL6 → ST3GAL1 |
| Downstream (Children) |
|---|
| ST3GAL1 → ATF4 (>>) |
| ST3GAL1 → CBFA2T3 (>>) |
| ST3GAL1 → CDR2 (>>) |
| ST3GAL1 → CHST7 (>>) |
| ST3GAL1 → CRLF3 (>>) |
| ST3GAL1 → CXCL14 (>>) |
| ST3GAL1 → FAM136A (>>) |
| ST3GAL1 → GAL (>>) |
| ST3GAL1 → GNE (>>) |
| ST3GAL1 → IFITM3 (>>) |
| ST3GAL1 → IGFBP3 (>>) |
| ST3GAL1 → ITPR2 (>>) |
| ST3GAL1 → KHDRBS1 (>>) |
| ST3GAL1 → MAN2A2 (>>) |
| ST3GAL1 → MKNK2 (>>) |
| ST3GAL1 → MLXIPL (>>) |
| ST3GAL1 → PIK3R1 (>>) |
| ST3GAL1 → PLCG2 (>>) |
| ST3GAL1 → PNPLA3 (>>) |
| ST3GAL1 → PPP2R5C (>>) |
| ST3GAL1 → PRDX6 (>>) |
| ST3GAL1 → PROCR (>>) |
| ST3GAL1 → PTK2B (>>) |
| ST3GAL1 → RAB22A (>>) |
| ST3GAL1 → RDX (>>) |
| ST3GAL1 → RORA (>>) |
| ST3GAL1 → RPS6KA1 (>>) |
| ST3GAL1 → SOCS2 (>>) |
| ST3GAL1 → UBE2L6 (>>) |
